The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-((5-chloro-2-((4-(((5-((diethylamino)methyl)furan-2-yl)methyl)thio)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)phenyl)methanesulfonamide ID: ALA4744925
PubChem CID: 162647808
Max Phase: Preclinical
Molecular Formula: C28H33ClN6O4S2
Molecular Weight: 617.20
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCN(CC)Cc1ccc(CSc2ccc(Nc3ncc(Cl)c(Nc4ccccc4NS(C)(=O)=O)n3)c(OC)c2)o1
Standard InChI: InChI=1S/C28H33ClN6O4S2/c1-5-35(6-2)17-19-11-12-20(39-19)18-40-21-13-14-25(26(15-21)38-3)32-28-30-16-22(29)27(33-28)31-23-9-7-8-10-24(23)34-41(4,36)37/h7-16,34H,5-6,17-18H2,1-4H3,(H2,30,31,32,33)
Standard InChI Key: UHLCVNSHMWCMPU-UHFFFAOYSA-N
Molfile:
RDKit 2D
41 44 0 0 0 0 0 0 0 0999 V2000
26.0511 -12.9595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8683 -12.9595 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
26.4597 -12.2518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8710 -10.5079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8698 -11.3274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5779 -11.7364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2875 -11.3269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2847 -10.5043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5761 -10.0990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5777 -12.5536 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.8697 -13.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9959 -11.7344 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.7029 -11.3247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4080 -11.7326 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.1145 -11.3236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1137 -10.5056 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4004 -10.0982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6967 -10.5096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9864 -10.1056 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
31.8227 -11.7315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.5300 -11.3221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2371 -11.7315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9439 -11.3229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9435 -10.5048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2303 -10.0971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5265 -10.5082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2369 -12.5487 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.5291 -12.9571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6502 -10.0945 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.3589 -10.5014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0656 -10.0911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8110 -10.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3564 -9.8122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9460 -9.1054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1472 -9.2774 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.2765 -8.3580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0890 -8.2706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.5649 -8.9310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3741 -8.8459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2277 -7.4381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4122 -7.5222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
6 10 1 0
10 2 1 0
2 11 1 0
7 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
18 19 1 0
15 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
22 27 1 0
27 28 1 0
24 29 1 0
29 30 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 31 1 0
34 36 1 0
36 37 1 0
37 38 1 0
37 41 1 0
38 39 1 0
40 41 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 617.20Molecular Weight (Monoisotopic): 616.1693AlogP: 6.72#Rotatable Bonds: 14Polar Surface Area: 121.62Molecular Species: NEUTRALHBA: 10HBD: 3#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.67CX Basic pKa: 8.33CX LogP: 4.59CX LogD: 3.76Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.13Np Likeness Score: -1.70
References 1. Guo M,Zuo D,Zhao T,Li X,Cao J,Qiu Y,Wei S,Zhai X. (2021) Structure-based optimization identified novel furyl-containing 2,4-diarylaminopyrimidine analogues as ALK/ROS1 dual inhibitors with anti-mutation effects., 214 [PMID:33581554 ] [10.1016/j.ejmech.2021.113259 ]